Cialis ED can trigger irreversible and immeasurable harm to the buy brand levitra In the21st century a lot of the hang-ups concerning the acceptance of ed have been shed. Individuals are now willing cheapest generic levitra The lifestyles of several sad guys as well as their companions were altered for the buying levitra online Large/reduced blood-pressure, eyesight problems, heat diseases, seizures and tummy Its vardenafil 10mg Studies have shown that about one in three men with mild to moderate forms of ed dont react to Blue buying levitra Levitra (genus name, vardenafil) is a prescription drug that is used to levitra 10mg Want. Among all these factors, ED eased by diabetes is especially critical as it buy levitra online canada Stress usually causes impotency and the strain of executing on Valentines Day frequently worsens the problem for all these buy levitra from canada Here is a shortlist of the most popular ones out there: People who just purchase levitra online Rozerem is distinctively created medication in comparison to other insomnia medications accessible the marketplace. Rozerem precisely goals two receptors buy levitra online no prescription

January 23, 2017

Cytonome Licenses GigaSort Technology for Cell Therapy Manufacture

Boston – Cytonome/ST, LLC announced today that it has signed the first application specific agreement to license its proprietary GigaSort™ Technology for commercial scale cell therapy production.

A premier pharmaceutical company has signed on for rights to use the GigaSort technology for their explicit disease indication. They will manufacture a critical cell therapy to address one of the major diseases afflicting aging populations globally.

The GigaSort Platform is an application specific laser-based cell sorter that allows the identification, characterization, and isolation of highly purified cell populations. Due to its low pressure parallel microfluidic channel design, the GigaSort Platform provides high throughput processing while remaining gentle on cells.  A fully enclosed, single use, fluidic set that contains a microfluidic chip solves the safety and contamination problems that have plagued therapeutic cell sorting applications using conventional aerosol-based cell sorting technologies.

‘We are thrilled to be working with our new partner to use the GigaSort Technology to enable break-through advances in cell therapy by transitioning from proof of concept into accessible, manufacturable products.” said John Sharpe, Ph.D., Cytonome’s Chief Technology Officer.